Northern Trust’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-24,205
Closed -$142K 4558
2023
Q4
$142K Sell
24,205
-279
-1% -$3.3K ﹤0.01% 4018
2023
Q3
$621K Buy
24,484
+5,086
+26% +$418K ﹤0.01% 3453
2023
Q2
$2.7M Buy
19,398
+4,584
+31% +$588K ﹤0.01% 2832
2023
Q1
$1.35M Buy
14,814
+229
+2% +$31.1K ﹤0.01% 3108
2022
Q4
$2M Sell
14,585
-225
-2% -$76.2K ﹤0.01% 2994
2022
Q3
$12.8M Sell
14,810
-481
-3% -$302K ﹤0.01% 1809
2022
Q2
$6.7M Buy
15,291
+11,421
+295% +$5.96M ﹤0.01% 2314
2022
Q1
$2.46M Buy
3,870
+11
+0.3% +$6.93K ﹤0.01% 2998
2021
Q4
$3.44M Buy
3,859
+149
+4% +$157K ﹤0.01% 2931
2021
Q3
$4.7M Buy
+3,710
New +$4.5M ﹤0.01% 2773

Other funds holding CANO

Northern Trust's CANO Position: Q1 2024 in Review

Northern Trust sold out of Cano Health, Inc. (CANO) in Q1 2024, closing a stake of 24,205 shares — an estimated $142K sold.

Northern Trust first reported a position in CANO in Q3 2021 and held it in 10 quarters. The position peaked at $12.8M in Q3 2022. 6 funds tracked by Wall St. Rank hold CANO as of Q1 2024.

  • Northern Trust reported no remaining Cano Health, Inc. position as of Q1 2024 after selling out during the quarter.
  • Northern Trust sold 24,205 Cano Health, Inc. shares in Q1 2024, an estimated $142K.
  • Northern Trust first reported a position in Cano Health, Inc. in Q3 2021 and held it in 10 quarters.
  • Northern Trust's Cano Health, Inc. position peaked at $12.8M in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2024.

Based on Northern Trust's 13F filing for Q1 2024, filed 14 May 2024.